Treatment adequacy for anxiety and depressive disorders in six European countries

The aims of this study are to describe the adequacy of treatment for anxiety and depressive disorders in Europe and how it differs between providers, using data from the ESEMeD study The overall proportion of adequate treatment was 45.8% (57.4% in the specialised sector and 23.3% in the general medical care sector). Between-country differences were found in treatment adequacy in the specialised setting. Organisational and political aspects may explain these findings. Declaration of interest Partial funding from several drug companies involved in the manufacture of antidepressant medication; full acknowledgements in a data supplement to the online version of this paper.